Biohaven Ltd. (BHVN)
NYSE: BHVN · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2022
Who runs Biohaven Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Coric Vlad
Chief Executive Officer. First filing Sep 2022, latest Mar 3, 2026, 8 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
14 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gentile Kimberly | SVP, Clinical Operations | Sep 2022 | Sep 17, 2026 | none |
| Volles Warren Karl | Chief Legal Officer | Jul 2026 | Jul 17, 2026 | none |
| Coric Vlad | Chief Executive Officer | Sep 2022 | Mar 3, 2026 | none |
| Buten Matthew | Chief Financial Officer | Sep 2022 | Mar 3, 2026 | none |
| Car Bruce | Chief Scientific Officer | Oct 2022 | Mar 3, 2026 | none |
| Clark George C. | VP, Chief Accounting Officer | Nov 2022 | Mar 3, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Yetimoglu John | director | Aug 2026 | Aug 14, 2026 | none |
| Antonijevic Irina | director | Sep 2022 | Apr 30, 2026 | none |
| Bailey Gregory | director | Sep 2022 | Apr 30, 2026 | none |
| Childs John W | director | Sep 2022 | Apr 30, 2026 | none |
| Gregory Julia P | director | Sep 2022 | Apr 30, 2026 | none |
| Heffernan Michael Thomas | director | Sep 2022 | Apr 30, 2026 | none |
| Hugin Robert J | director | Sep 2022 | Apr 30, 2026 | none |
| Mehta Kishan | director | Sep 2022 | Apr 30, 2026 | none |
Earlier names on the record1, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.